1 型糖尿病患者的 GLP-1 受体激动剂和 SGLT2 抑制剂处方。

{"title":"1 型糖尿病患者的 GLP-1 受体激动剂和 SGLT2 抑制剂处方。","authors":"Piaopiao Li,Zhiyan Li,Elizabeth Staton,Guillermo E Umpierrez,Georgia Davis,Hui Shao,Francisco J Pasquel","doi":"10.1001/jama.2024.18581","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"63 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes.\",\"authors\":\"Piaopiao Li,Zhiyan Li,Elizabeth Staton,Guillermo E Umpierrez,Georgia Davis,Hui Shao,Francisco J Pasquel\",\"doi\":\"10.1001/jama.2024.18581\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":518009,\"journal\":{\"name\":\"JAMA\",\"volume\":\"63 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/jama.2024.18581\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jama.2024.18581","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}